Regulations.gov document
Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of…
Other · FDA-2018-D-1216 · posted Jan 21, 2022
Key facts
| Document ID | FDA-2018-D-1216-0021 |
|---|---|
| Title | Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic Nonalcoholic Steatohepatitis (NASH); Guidance for Industry; Technical Specifications Document |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2018-D-1216 |
| Posted | Jan 21, 2022 |
| Comment period opens | Jan 21, 2022 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: